Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Communications to the International Sarcopenia Translational Research Conference 2021.

ABSTRACT:

SUBMITTER:

PROVIDER: S-EPMC8419847 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

Communications to the International Sarcopenia Translational Research Conference 2021.

Journal of frailty, sarcopenia and falls 20210901 3

PMID: 34557616

Similar Datasets

Communications to the International Sarcopenia Translational Research Conference 2023.

Project description: Not available

| S-EPMC10690130 | biostudies-literature

Abstract: Symposia, Conferences, Oral communications: 11th International Conference on Frailty, Sarcopenia Research and Geroscience (ICFSR), September 29 - October 2, 2021.

Project description: Not available

| S-EPMC8478633 | biostudies-literature

Integrating basic science with translational research: the 13th International Podocyte Conference 2021.

Project description:The 13th International Podocyte Conference was held in Manchester, UK, and online from July 28 to 30, 2021. Originally planned for 2020, this biannual meeting was postponed by a year because of the coronavirus disease 2019 (COVID-19) pandemic and proceeded as an innovative hybrid meeting. In addition to in-person attendance, online registration was offered, and this attracted 490 conference registrations in total. As a Podocyte Conference first, a day for early-career researchers was introduced. This premeeting included talks from graduate students and postdoctoral researchers. It gave early career researchers the opportunity to ask a panel, comprising academic leaders and journal editors, about career pathways and the future for podocyte research. The main meeting over 3 days included a keynote talk and 4 focused sessions each day incorporating invited talks, followed by selected abstract presentations, and an open panel discussion. The conference concluded with a Patient Day, which brought together patients, clinicians, researchers, and industry representatives. The Patient Day was an interactive and diverse day. As well as updates on improving diagnosis and potential new therapies, the Patient Day included a PodoArt competition, exercise and cooking classes with practical nutrition advice, and inspirational stories from patients and family members. This review summarizes the exciting science presented during the 13th International Podocyte Conference and demonstrates the resilience of researchers during a global pandemic.

| S-EPMC9386279 | biostudies-literature

Abstract: Posters: 11th International Conference on Frailty, Sarcopenia Research and Geroscience (ICFSR), September 29 - October 2, 2021.

Project description: Not available

| S-EPMC8478630 | biostudies-literature

Abstract: Symposia, Conferences, Oral communications: 10th International Conference on Frailty, Sarcopenia Research and Geroscience (ICFSR), March 11-13, 2020, Toulouse - France.

Project description: Not available

| S-EPMC7223136 | biostudies-literature

13th International Conference on Frailty & Sarcopenia Research (ICFSR) : March 22–24, 2023 Toulouse, France

Project description: Not available

| S-EPMC10040174 | biostudies-literature

Challenges in the Development of Drugs for Sarcopenia and Frailty - Report from the International Conference on Frailty and Sarcopenia Research (ICFSR) Task Force.

Project description:Sarcopenia and frailty represent two burdensome conditions, contributing to a broad spectrum of adverse outcomes. The International Conference on Frailty and Sarcopenia Research (ICFSR) Task Force met virtually in September 2021 to discuss the challenges in the development of drugs for sarcopenia and frailty. Lifestyle interventions are the current mainstay of treatment options in the prevention and management of both conditions. However, pharmacological agents are needed for people who do not respond to lifestyle modifications, for those who are unable to adhere, or for whom such interventions are inaccessible/unfeasible. Preliminary results of ongoing trials were presented and discussed. Several pharmacological candidates are currently under clinical evaluation with promising early results, but none have been approved for either frailty or sarcopenia. The COVID-19 pandemic has reshaped how clinical trials are conducted, in particular by enhancing the usefulness of remote technologies and assessments/interventions.

| S-EPMC9017069 | biostudies-literature

Abstract: Posters: 10th International Conference on Frailty, Sarcopenia Research and Geroscience (ICFSR), March 11-13, 2020, Toulouse - France.

Project description: Not available

| S-EPMC7223455 | biostudies-literature

The Twenty-Second International Conference on Antiviral Research

Project description: Not available

| S-EPMC7125517 | biostudies-literature

The Twenty-First International Conference on Antiviral Research

Project description: Not available

| S-EPMC7125535 | biostudies-literature